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Abstract
Background: Syngonanthus arthrotrichus and Syngonanthus bisulcatus, currently known for Comanthera aciphylla
(Bong.) L.R.Parra & Giul. and Comanthera bisulcata (Koern.) L.R. Parra & Giul, popularly known in Brazil as “sempre-vivas,”
are plants from the family Eriocaulaceae. They are found in the states of Minas Gerais and Bahia. The species are known to
be rich in flavonoids to which their gastroprotective activity has been attributed. In this research, experimental protocols
were performed to elucidate the associated mechanisms of action.
Methods: The activity was evaluated using induced gastric ulcer models (acetic acid and ethanol-induced gastric lesions
in NEM or L-NAME pre-treated mice, and by ischemia/reperfusion). Antioxidant enzymes, serum somatostatin, and gastrin
were also evaluated.
Results: In chronic gastric ulcers, a single daily oral dose of Sa-FRF or Sb-FRF (100 mg/kg body wt.) for 14 consecutive
days accelerated ulcer healing to an extent similar to that seen with an equal dose of cimetidine. The pre-treatment of
mice with NEM (N-ethylmaleimide) or L-NAME (N-nitro-L-arginine) abolished the protective activity of Sa-FRF, Sa-FDF,
Sb-FDF and Sb-FRF or Sa-FRF and Sb-FRF, respectively, which indicates that antioxidant compounds and nitric oxide
synthase activity are involved in the gastroprotective. Sa-FRF and Sb-FRF (100 mg/kg p.o) protected the gastric
mucosa against ulceration that was induced by ischemia/reperfusion (72 and 76 %, respectively). It also decreased
lipid peroxidation and restored total thiols in the gastric wall of mice that had been treated with ethanol. When
administered to rats submitted to ethanol-induced gastric lesions, Sa-FRF and Sb-FRF (100 mg/kg, p.o.) increased
the somatostatin serum levels, while the gastrin serum levels were proportionally decreased.
Conclusions: The results indicate significant healing effects and gastroprotective activity for the Sa-FRF and Sb-FRF,
which probably involves the participation of SH groups, nitric oxide (NO), the antioxidant system, somatostatin, and
gastrin. All are integral parts of the gastrointestinal mucosa’s cytoprotective mechanisms against aggressive factors.
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Background
Gastric ulcer is a disease that affects many people around
the world, and its progression is attributed to an imbal-
ance between aggressive factors (acid, pepsin, Helicobacter
pylori, stress, alcohol, and continued use of non-steroidal
anti-inflammatory drugs), and protective factors (mucus,
bicarbonate, prostaglandin, blood flow, the antioxidant
system, sulfhydryl compounds, nitric oxide and cell prolif-
eration) [1–3].
Gastric ulcer is a common disease with multiple etiolo-
gies. Factors such as smoking, stress, an improper diet,
and gastro-protective deficiencies are closely related to the
development of gastric mucosa ulceration. Bacterial infec-
tion with Helicobacter pylori has also been highlighted as
an important predisposing factor for developing gastric
ulcers [4].
Thru the years, a great store of knowledge has been ac-
quired concerning the development of gastric ulcer, and a
broad spectrum of drugs for its treatment such as antacids,
proton pump inhibitors, anticholinergics, and histamine
receptor antagonists [5], has developed. Nevertheless,
the existing therapies commonly have adverse effects
(hypersensitivity, arrhythmia, impotence, gynecomastia
and hematopoietic changes), and are expensive. This
has stimulated continued research for new therapeutic
alternatives. At this point, we insert medicinal plants
for their various advantages such as greater availability,
more effective protection, lower cost, and lower tox-
icity [6, 7].
The early search in the area of medicinal plant in the
treatment of peptic ulcers opened the discovery of the
first drug effective against peptic ulcer; carbenoxolone
from Glycyrrhiza glabra [8–10], and licorice root fluid
extract were used to treat stomach ulcers in patients had
not improved with conventional medication. The glycyr-
rhizin of licorice was found to stop two enzymes that
break down prostaglandin E [11]. Effectiveness of other
plant resources as cabbage in improving peptic ulcers
have been reported [12–14].
Among the medicinal plants presented as candidates
for the treatment of gastric ulcer we note those belong-
ing to the Eriocaulaceae family. The family consists of
more than 10 genera, being roughly 1200 species.
Though it has a pan tropical distribution, most species
occur in near tropical regions, such as in the moun-
tains of Venezuela, or in Brazil [15–17]. Eriocaulaceae
is the dominant herbal family of the Cipó Mountain
range in the state of Minas Gerais, Brazil. We focused
on species belonging to the genus Syngonanthus
(Comanthera), S. arthrotrichus, and S. bisulcatus.
These species are currently known as Comanthera aci-
phylla and Comanthera bisulcata [18], respectively,
and popularly known as “sempre-vivas-mini-saia” and
“sempre-vivas-chapadeira".
The phytochemical screening of the extracts of Syngo-
nanthus bisulcatus (Comanthera bisulcata (Koern.) L.R.
Parra & Giul) and Syngonanthus artrotrichus (Comanthera
aciphylla (Bong.) L.R.Parra & Giul) performed by Batista
[19] showed that the main compounds present in the ex-
tracts were flavonoids and phenolic compounds.
The chromatographic study of the flavonoid rich frac-
tions obtained from the scapes of the species S. bisulcatus
and S. arthrotricus was performed as described by Batista
[19]. The species Syngonanthus bisulcatus presented major
compounds such as luteolin and glycosylated derivatives
of luteolin confirming the previous studies described by
Agrawal [20] and Harbone [21].
Studies performed by Coelho [22] showed in this
fraction also the presence of isovitexin, lutonarine and
5, 6, 3’, 4’-tetrahidroxi-7-O-D-glucopiranosilflavone. In
the flavonoid rich fractions of Syngonanthus arthrotri-
chus was possible to isolate the compound luteolin. In
studies previously described by Agrawal [20] and Rinaldi
[23] were also identified luteolina, apigenin and luteolin-
6-C-β-D-glucopiranoside.
Research has shown that medicinal plants promote
anti-inflammatory, antioxidant, and gastroprotective ef-
fects [24–29]. The gastroprotective activity promoted by
flavonoids has been demonstrated in a literature review
published by Mota et al. [30]. Studies performed by our
group have shown the gastroprotective activity of plant
species such as S. arthrotrichus [31], S. bisulcatus [32],
and S. macrolepsis [33] all of which were collected in the
state of Minas Gerais, Brazil.
Considering the above, we aimed to explore gastropro-
tective effects promoted by fractions obtained from S.
arthrotrichus and S. bisulcatus, using varied induced
gastric ulcer models, to thus evaluate the mechanisms of
action involved.
Methods
Animals
The experimental protocols were approved by the
Committee for Ethics in Animal Experimentation (CEEA/
UNICAMP) with register number 502–1, in 2002. Male
Swiss albino mice (30–40 g) or male Wistar albino rats
(180–250 g), from the Central Animal House of the State
University of Campinas (CEMIB/UNICAMP) were used.
The animals were fed a certified Nuvilab CR-diet, and in
addition, had free access to water under fixed conditions
of illumination (12/12 h light/dark cycle), humidity (60 ±
1.0 %), and a temperature of (21,5° ± 1.0). Fasting was used
prior to all assays, because standard drugs were adminis-
tered orally (by gavage), or by the intra-duodenal route
using a 0.9 % saline solution (10 mL/kg) as the vehicle
(negative control). The animals were kept in cages with
raised wide mesh floors to prevent coprophagy.
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Drugs
The drugs and reagents were prepared immediately before
use. The following drugs were used: cimetidine (Sigma
Chemical Co, USA), lansoprazole (Aché, Brazil), absolute
ethanol (Merck, Germany), hydrochloric acid (Merck,
Germany), Nω-Nitro-L-arginine methyl ester hydrochlor-
ide (Sigma Chemical Co, USA), and N-Ethylmaleimide
(Sigma Chemical Co, USA). All drugs and fractions were
administered orally (gavage), or intraduodenally.
Plant material
Scapes of S. arthrotrichus, and S. bisulcatus were collected
in 2002 at Cipó Mountain, Diamantina City, in the state
Minas Gerais, Brazil. S. arthrotrichus was authenticated by
Dr. Ana Maria Giulietti, and S. bisulcatus was authenti-
cated by Dr. Paulo Takeo Sano. A voucher of each speci-
men (n° 2122 and 2137, respectively) was deposited in the
Herbarium of the Department of Botany, at the Institute of
Biosciences, USP.
Scapes (500 g) of S. arthrotrichus and S. bisulcatus col-
lected in the Serra do Cipó, Minas Gerais, were dried in
an oven at 60 °C for 4 d and then powdered. The resulting
material was macerated sequentially at room temperature
in methylene chloride, EEOH and 70 % EEOH for one
week with each solvent. The extracts were filtered and
concentrated under vacuum. The EEOH and 70 % EEOH
extracts were analyzed by TLC on silica gel plates using n-
BuOH/HOAc/H2O (6:1:2, v/v/v). The TLC spots were
detected using UV light and NP/PEG reagent which yields
yellow or orange spots characteristic of flavonoids. Since
these extracts contained material with similar retention
factors (Rf ), they were combined and weighed. A sample
(3.5 g) of the ethanolic extract was dissolved in 10 ml of
MeOH and fractionated on a Sephadex LH-20 CC column
(10033 cm). The extract was eluted in MeOH at a flow
rate of 0.5 ml/min and 3 ml fractions were collected. The
fractions were combined based on their migration in the
TLC system described above. Fractions 1–22 were defi-
cient in flavonoids, fractions 23–47 were intermediate
fractions and fractions 58–64 were rich in flavonoids and
were administered at a dose of 100 mg/Kg.
Healing in acetic acid-induced gastric lesion
The experiment was performed according to the method
described by Takagi et al. [34], with some modifications.
After fasting for 24 h, and under anesthesia, a laparotomy
was performed on all animals through a midline epigastric
incision. After exposing the stomach, a 30 % (v/v) acetic
acid solution (0.05 mL) was injected into the subserosal
layer in the glandular part of the anterior wall. The abdo-
men was then closed and all the animals were fed
normally. Two days after the acetic acid indution of
gastric lesion, treatments were initiated with oral adminis-
trations of Sa-FRF, Sa-FDF; Sb-FRF, Sb-FDF; cimetidine
(100 mg/kg); or 0.9 % saline solution at 10 mL/kg. All
treatments were administered orally once a day for 14
consecutive days. On the day after the last drug adminis-
tration, (and after fasting for 12 h), the rats were sacri-
ficed, and their stomachs then removed. The macroscopic
ulcer lesion area (ULA) of the internal and external bor-
ders in mm2 were determined as described in the method.
Ethanol-induced gastric lesions in NEM pre-treated mice
The mice were divided into groups (n = 5–7 animals),
and were fasted for 24 h. They were then treated intra-
peritoneally with NEM (N-ethylmaleimide) at 10 mg/kg,
or 0.9 % saline solution at 10 mL/kg. At thirty minutes,
the groups received an oral dose of either 0.9 % saline
solution, Sa-FRF, Sa-FDF, Sb-FRF or Sb-FDF. After
60 min, all groups were orally treated with 0.2 mL of HCl/
ethanol to induce gastric-ulcer [35]. One hour after the
administration of HCl/ethanol the animals were eutha-
nized by cervical dislocation and their stomachs were
excised. Gastric damage was determined using the ulcera-
tive index (UI) as described by Szelenyi and Thiemer [36].
Ethanol-induced gastric mucosal lesion in
L-NAME-pre-treated mice
The mice were fasted for 24 hours and divided into 3
groups (n = 5–7), according to pre-treatments: one group
received 0.9 % saline solution (10 mL/kg, s.c.), and two
groups received Nω-L-arginine methyl ester (L-NAME),
an oxide synthase blocking agent, at 70 mg/kg (s.c.). Thirty
minutes after administration, the groups were orally
treated with either 0.9 % saline solution, Sa-FRF, Sa-FDF,
Sb-FRF or Sb-FDF. Sixty minutes later, all groups were
treated orally with 0.2 mL HCl/ethanol to induce gastric
ulcer [37]. One hour later, the animals were euthanized by
cervical dislocation, the stomachs were excised, and gas-
tric damage was determined as previously described.
Gastric lesion induced by ischemia/reperfusion
Ischemia/reperfusion damage was produced in the rats
by a method proposed by Ueda et al. [38]. The rats were
fasted for 24 hours and divided (according to pre-
treatment) into four groups (n = 5–7): normal (no pre-
treatment and neither ischemia nor reperfusion), sham
(no pre-treatment), 0.9 % saline (10 mL/kg), and Sa-FRF
or Sb-FRF. After 15 min, the rats were anaesthetized by
an intramuscular injection of Ketamine (50 mg/kg) and
Xylazine (10 mg/kg). The left side of the abdomen was
shaved, and an incision was made. Briefly, the celiac
artery was dissected, free of excess fat, and clamped for
30 minutes (ischemia phase), using a micro-bulldog
clamp. Re-oxygenation was then allowed by removal of
the clamp for 60 min (reperfusion phase). The macro-
scopic ulcer lesion area were determined.
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Antioxidant activity
To assess the effects of the Sa-FRF and Sb-FRF on the anti-
oxidative system, we assayed lipid peroxidation, and the
levels of sulfhydryls (GSH), in the glandular stomach mu-
cosa in those rats with ischemia/reperfusion gastric lesions.
Lipid Peroxidation (LPO)
The total thiobarbituric acid-reactive substances (TBARS)
level in gastric tissue, (an index of malonyldialdehyde
(MDA) production), was determined according to the
method developed by Ohkawa et al. [39]. Gastric segments
were cut into small pieces and then homogenized in an
ice-cold phosphate buffer (50 mM, pH 7.4), to give a 10 %
homogenate. The homogenate of the glandular portion of
stomach was diluted in 0.15 M KCl (ratio 1:10). Then to
0.5 mL of this homogenate were added 0.2 mL of dodecyl
sulfate (8.1 %), 1.5 ml of acetic acid 20 %, (adjusted with
an NaOH solution to pH 3.5), 1.5 ml of thiobarbituric acid
(0.8 % w/v), and 0.3 mL of distilled water. Subsequently,
the mixture was heated in a water bath (bain-marie) with
the thermostat set at 95 °C for 1 hour. After this, the sam-
ples were cooled and added to 1 mL of distilled water, and
5 mL of an n-buthanol + pyridine (15:1, v/v) mixture, and
shaken in a vortex for 1 min, and then centrifuged at
1400 G for 10 minutes. Finally the absorbance was read at
532 nm. TEPP (1,1,3,3-tetraethoxypropane) diluted in etha-
nol was used as the standard. The results were expressed
as picomoles of the substances reacting with the thiobarbi-
turic acid (TBARS), per mg of protein (nmol TBARS . mg
protein−1).
Total thiol groups in stomach homogenate
The total thiols in the gastric tissue were determined ac-
cording to the Faure and Lafond [40] method with modifi-
cations. Briefly, 500 μL of 0.25 mM Tris, and 20 mM
EDTA solution (pH 8.2), was added to an aliquot (100 mL)
of the homogenate (in a phosphate 10 mM buffer, pH 7.8)
obtained from the stomach scraping. The absorbance (A1)
of the final solution was determined by spectrophotometer
at 412 nm. Then, 10 μL of 5-5’-dithio-bis (2-nitrobenzoic
acid) (DTNB) 10 mM (diluted in methanol) was added to
the mixture. After 15 min, we took a second reading (A2).
DTNB diluted in buffer was used as blank (B). To calculate
the sulfhydryl groups concentration we used the following
equation: (A2 – A1-B) × 1,57 mM. The results were
expressed in nmol TBARS/mg protein × 103.
Serum somatostatin and gastrin
To perform this protocol, gastric lesions were induced by
oral administration of absolute ethanol 1 mL [41]. Thirty
minutes before lesion induction, the animals received an
oral dose of the 0.9 % saline solution, lansoprazole
(30 mg/kg), Sa-FRF or Sb-FRF. One hour after ethanol ad-
ministration; blood was collected by the abdominal aorta
and placed into tubes containing EDTA. The sample was
centrifuged at 3000 G for 15 minutes, and the plasma ob-
tained from each sample was stored at −20 ° C until serum
somatostatin and gastrin determinations.
Somatostatin
The somatostatin dosage in the plasma of the animals
was performed according to methodology described by
Arimura et al. [42], using a radioimmunoassay “kit”
EURIA-Somatostatin (RB-306, Eurodiagnóstica). Re-
sidual radioactivity was determined in a gamma scintil-
lation counter (Beckman, model G5500), with a time of
2–4 minutes.
Gastrin
Plasma gastrin determination was performed according
to the method described by Slingerland et al. [43], using
a radioimmunoassay “kit” (CIS bio International -
GASK-PR). Residual radioactivity was determined in a
gamma scintillation counter (Beckman, Model G5500)
for 1 minute.
Statistical analysis
Results were expressed as mean ± S.D. or mean ± S.E.M.
Statistical significance between groups was determined
by one-way analysis of variance (ANOVA) followed by
Dunnett’s tests, with p < 0.05 considered significant. The
statistical software program utilized was GraphPad
Prism® version 4 (U.S.A., 2003).
Results
Healing in acetic acid-induced gastric lesion
The effects of the S. arthrotrichus and S. bisulcatus
fractions in the acetic acid-induced gastric lesion model
are shown in Table 1. The results show that the Sa-FRF
(42 ± 1,6*), Sb-FRF (49 ± 4,3*), and cimetidine (22 ± 2,5**)
significantly reduced the ULA, when compared to the
saline group (75 ± 8,6). Yet, Sa-FDF and Sb-FDF did not
promote significant protection. These results suggest that
Sa-FRF and Sb-FRF demonstrated healing of the lesions
induced by acetic acid.
Ethanol-induced gastric lesions in NEM pre-treated rats
For ethanol-induced gastric lesions in the NEM pre-
treated rats model, we observed that when the groups were
pre-treated with NEM (a sulfhydryl group blocker), and
treated with either Sa-FRF (53 ± 11**), Sa-FDF (56 ± 13**),
Sb-FRF (56 ± 11*), Sb-FDF (69 ± 17*), or saline (76 ± 21**,
83 ± 14*) an increase of the UI occurred when compared
to the controls (27 ± 8) (Table 2). The results demonstrate
that the sulfhydryl compounds pathway is involved in the
gastroprotective effect promoted by the fractions studied.
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Ethanol-induced gastric mucosal lesion in
L-NAME-pre-treated rats
We observed that groups pretreated with L-NAME and
subsequently treated orally with the Sa-FRF (39 ± 5,4*)
or Sb-FRF (32 ± 6,3*) displayed an increase of the UI
when compared to their respective saline control groups
(17 ± 5,5, 16 ± 5,7) (Table 3). Sa-FDF and Sb-FDF did not
promote significant UI changes. The results suggest that
NO is related to the gastroprotective effects promoted
by Sa-FRF and Sb-FRF.
Gastric lesion induced by ischemia/reperfusion
Pretreatment with the Sa-FRF or Sb-FRF significantly pro-
tected the gastric mucosa against gastric lesion induced by
ischemia/reperfusion (52 ± 15* and 41 ± 25*, respectively),
when compared with the saline group (181 ± 26) (Table 4).
These results suggest that Sa-FRF and Sb-FRF protect the
gastric mucosa from ischemia/reperfusion-related injuries.
Antioxidant activity
Lipid Peroxidation (LPO)
We observed a significant decrease in lipid peroxida-
tion for the treated rats with Sa-FRF (47 ± 8,1**), and
Sb-FRF (51 ± 6,6**) when compared with the saline group
(115 ± 8,9). Hence, substances present in either fraction
may well be associated with antioxidant activity (Table 5).
Total thiol groups in stomach homogenate
The levels of total thiols increased in the rats treated
with flavonoid rich fractions obtained from S. arthrotri-
chus (24 ± 4,2**), and S. bisulcatus (21 ± 6,7*) when com-
pared with the saline group (13 ± 2,7). Decreasing GSH
was prevented by treatment with the studied plant samples
(Table 5).
Serum Somatostatin and Gastrin
According to the results for the somatostatin model, we
observe that the Sa-FRF (77 ± 17*), the Sb-FRF (82 ± 8,2*),
and lanzoprazole (88 ± 22*) significantly increased serum
somatostatin levels when compared with the saline
group (20 ± 7,5). On the other hand we also observed
that animals treated with Sa-FRF (59 ± 20*), and Sb-FRF
(76 ± 9,3*) showed significant reductions in serum gastrin
levels when compared to the control group (349 ± 22).
This suggests that the gastroprotective effects promoted
by both S. arthrotrichus, and S. bisulcatus are associated
with inhibition of gastric acid secretion (Table 6).
Discussion
In the present study we investigated the healing activity,
and possible mechanisms of action involved in the gastro-
protective effects promoted by the S. arthrotrichus and S.
bisulcatus species. Previous studies conducted by Batista
et al. [31, 32] have demonstrated that significant gastro-
protective effects are promoted by ethanolic extracts, and
Table 1 Effects of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus on healing in acetic acid-induced
gastric lesion
Gastric lesion models Treatment (p.o.) Dose (mg/kg) ALU (mm2) Inhibition (%)
Acetic acid Saline - 75 ± 8,6 -
Cimetidine 100 22 ± 2,5** 71
Sa-FRF 100 42 ± 1,6* 44
Sa-FDF 100 65 ± 7,0 13
Sb-FRF 100 49 ± 4,3* 35
Sb-FDF 100 67 ± 25 11
ANOVA followed by Dunnett’s test.*p < 0.05, **p < 0.01. Data are presented as mean ± S.D (n = 5-7)
Table 2 Effects of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus on gastric lesions induced by
ethanol in rats pretreated with NEM
Pretreatment Treatment (p.o.) Dose (mg/kg) UI (mm) Increase Lesion (%)
Saline Saline 10 27 ± 8 -
NEM (10 mg/Kg) Saline 10 76 ± 21** 181
NEM (10 mg/Kg) Sa-FRF 100 53 ± 11** 96
NEM (10 mg/Kg) Sa-FDF 100 56 ± 13** 107
Saline Saline 10 27 ± 8 -
NEM (10 mg/Kg) Saline 10 83 ± 14* 207
NEM (10 mg/Kg) Sb-FRF 100 56 ± 11* 107
NEM (10 mg/Kg) Sb-FDF 100 69 ± 17* 155
ANOVA followed by Dunnett’s test.* p < 0.05, ** p < 0.01. Data are presented as mean ± S.D (n = 5-7)
Batista et al. BMC Complementary and Alternative Medicine  (2015) 15:391 Page 5 of 9
fractions (FRF, and FDF at doses of 100 mg/ kg), in acute
gastric ulcer induced-models. The best results were ob-
tained with the flavonoid fractions, and this encouraged
our research group to continue the study, focusing on the
Sa-FRF, Sa-FDF, Sb-FRF and Sb-FDF.
Healing and gastroprotective effects promoted by medi-
cinal plants have been widely investigated in a number of
studies [44–46]. The acetic acid induced gastric ulcer
model in rats has been used to evaluate healing activity for
many years. Acetic acid-induced lesions most resemble the
ulcers occurring in man in terms of location, severity, and
chronicity as well as in the physiological processes related
to healing [47]. It is known that the healing process in-
volves cell proliferation and migration, restoration of the
gland architecture, angiogenesis, and matrix deposition
[48–50]. Histamine H2-receptor antagonists and proton-
pump inhibitors generally accelerate the healing of gastric
ulcers through their potent and long-lasting antisecretory
actions [51].
The results obtained in our experiments confirmed
that animals treated with Sa-FRF or Sb-FRF enjoyed sig-
nificant cure rates when compared to the control group.
The results suggest healing promotion. The good results
obtained with Sa-FRF and Sb-FRF encouraged the au-
thors to continue the research with experimental proto-
cols assessing the contribution of sulfhydryl groups to
the gastroprotective effect.
Non-protein sulfhydryl compounds (NP-SH) play an
important role, scavenging free radicals, as well as acting
against toxic substances that are either ingested or pro-
duced in the intestines. These groups act by binding to
free radicals or by forming disulfide bonds in the gastric
mucus, thus preventing cleavage [52, 53]. L-NAME
pretreatment of the Sa-FRF, Sa-FDF, Sb-FRF or Sb-FDF
animals increased the UI when compared to the con-
trols. These results suggest that the protective effects of
analyzed fractions of the species studied are dependent
on sulfhydryl compounds.
The release of nitric oxide (NO) causes vasodilation of
sub-mucosal arterioles, and increases blood flow. This
increase in blood flow improves the buffering capacity of
the gastric acid entering the lamina propria as well as
helping to dilute and remove other toxins that cross the
epithelium [54]. Furthermore, nitric oxide participates in
gastric defense mechanisms by regulating acid, alkaline,
and mucus secretions [55].
The results showed that the UI significantly increased in
groups pretreated with L-NAME compared to the control
group. However, the UI increases in animals pretreated
with the FRFs (of both species), were lower than those ob-
tained in the absence of these fractions, which indicates
that some gastric mucosa protection is afforded by the
FRFs. When comparing pre-treatments with FDFs, of both
species, we found that they blocked completely any wors-
ening of L-NAME-induced lesions. This suggests that the
mechanism of action (where the FRFs of both species
failed to protect the gastric mucosa) is dependent on NO.
The effects exerted by the FDFs were not dependent NO.
Table 3 Effects of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus on gastric lesions induced by
ethanol in rats pretreated with L-NAME
Pretreatment Treatment (p.o.) Dose (mg/kg) UI (mm) Increase lesion (%)
Saline Saline 10 17 ± 5,5 -
L-NAME (70 mg/Kg) Saline 10 59 ± 15* 247
L-NAME (70 mg/Kg) Sa-FRF 100 39 ± 5,4* 129
L-NAME (70 mg/Kg) Sa-FDF 22 ± 1,9 29
Saline Saline 10 16 ± 5,7 -
L-NAME (70 mg/Kg) Saline 10 60 ± 14** 275
L-NAME (70 mg/Kg) Sb-FRF 100 32 ± 6,3* 100
L-NAME (70 mg/Kg) Sb-FDF 100 20 ± 3,5 25
ANOVA followed by Dunnett’s test.*p < 0.05, **p < 0.01. Data are presented as mean ± S.D (n = 5-7)
Table 4 Effects of the flavonoid-rich fraction (FRF) from Syngonanthus arthrotrichus and Syngonanthus bisulcatus on gastric lesions
induced by ischemia and reperfusion
Gastric lesion models Treatment (p.o.) Dose (mg/kg) ALU (mm2) Inhibition (%)
Ischemia and Reperfusion Normal - - -
Saline 10 181 ± 26 0
Sham - 156 ± 29 14
Sa-FRF 100 52 ± 15* 72
Sb-FRF 100 41 ± 25* 76
ANOVA followed by Dunnett’s test.*p < 0.05, **p < 0.01. Data are presented as mean ± S.D (n = 5-7)
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Gastric ischemia and reperfusion relates to important
indices of morbidity and mortality, in episodes of
hemorrhagic shock, bleeding ulcers, and diseases of the
gastrointestinal tract. The available treatments for is-
chemia and gastric reperfusion related injuries are still
underperformers; and the search for sources of new
therapeutics has become important [56]. Our next step
was to evaluate gastroprotective effects against gastric
ulcers as induced by ischemia and reperfusion.
Ischemia and reperfusion cause the release of factors
responsible for tissue damage, such as reactive oxygen
species, and chemotaxis of inflammatory cells, with the
consequent release of pro-inflammatory mediators
[57–60]. Ischemia breaks the gastric mucous barrier, and
increases back-diffusion of acid, thus predisposing the gas-
tric mucosa to injury. In turn, after reperfusion the forma-
tion of reactive oxygen species from the xanthine oxidase
system occurs, which leads to lipid peroxidation which
along with gastric secretion results in cell injury and death
[61, 62]. The results suggest that the Sa-FRF and Sb-FRF
display gastroprotective activity at the dose evaluated. This
protection could reflect antioxidant and anti-inflammatory
activities promoted by the plant samples studied.
Continuing the study, we performed tests to confirm
pro-antioxidant activity. For this we used homogenates of
the rat stomachs (having been first submitted to ischemia
and reperfusion), with the aim of determining total thiols,
and lipid peroxidation.
Experimental evidence indicates that depletion of cellular
GSH levels leads to accumulation of reactive oxygen
species, which may be responsible for aggravating the
gastric ulceration process [63]. Increases in the levels of re-
active oxygen species are directly related to lipid peroxida-
tion. This can be observed in the formation of products
such as MDA [64, 65].
Our results show that animals treated with Sa-FRF or
Sb-FRF, and then subjected to ischemia and reperfusion
were able to prevent lipid peroxidation, as well as reverse
reductions in thiol levels for the injured gastric tissue.
Based on these results, antioxidant activity is inferred for
the plant samples. At this stage of the study, the authors
judged the mechanisms of action to be only partially
understood, with certain effects related to gastric acid se-
cretion needing to be further clarified. Therefore experi-
ments to evaluate the impact of plant samples on serum
levels of gastrin and somatostatin were performed.
Somatostatin, produced by D cells in the mucosa of the
stomach and pancreas is a regulator of stomach acid, and
gastrin [66] releases. In ulcerated animals, plasma somato-
statin levels decrease [67]. When the plasma levels of
somatostatin were determined in the rats pretreated with
S. bisulcatus and S. artrotrichus FRF at 100 mg/kg, in-
creases in these hormone levels were observed in relation
to the control group. This suggested our hypothesis that
the protective mechanism of the FRFs involves inhibition
of gastric acid secretion.
Gastrin, produced by G cells of the stomach and the duo-
denum, in turn, stimulates parietal cell cholecystokinin-β
receptors through elevated intracellular calcium levels, and
increases acid secretion [68, 69]. It has been observed that
in ulcerated animals, plasma gastrin levels increase [67].
When we investigated the possible hormonal role of FRFs
(for pre-treated animals) in gastrin secretion, we observed
that there was a significant reduction in gastrin plasma
levels. These data confirmed the involvement of the Syngo-
nanthus fractions in gastric acid secretion mechanisms,
and explain part of the gastroprotective activity of the plant
samples studied.
Conclusion
In conclusion, our results suggest that both S. bisulcatus
and S. artrotrichus FRFs were responsible for wound heal-
ing in acetic acid induced ulcers. The anti-ulcer activity is
Table 5 Effects of the flavonoid-rich fraction (FRF) from Syngonanthus arthrotrichus and Syngonanthus bisulcatus on the activities of
antioxidative enzymes in the gastric mucosa of rats with ethanol–induced lesions
Treatments Dose (mg/kg) Lipid peroxidation (TBARS/mg protein x 10−3) Inibition (%) Total thiols ( μmol/mg protein) Increase (%)
Saline - 115 ± 8,9 - 13 ± 2,7 -
Sham 10 98 ± 6,7* 15 15 ± 5,9 15
Normal - 49 ± 8,3** 57 31 ± 7,2** 138
Sa-FRF 100 47 ± 8,1** 59 24 ± 4,2** 61
Sb-FRF 100 51 ± 6,6** 56 21 ± 6,7* 84
ANOVA followed by Dunnett’s test.* p < 0.05, ** p < 0.01. Data are presented as mean ± S.D (n = 5-7)
Table 6 Effects of the flavonoid-rich fraction (FRF) from Syngo-
nanthus arthrotrichus and Syngonanthus bisulcatus on the serum
somatostatine and gastrin
Treatment (p.o.) Somatostatin (pmol/L) Gastrin (μU/mL)
Sham 21 ± 1,5 334 ± 15
Saline 20 ± 7,5 349 ± 22
Lansoprazole 88 ± 22* 47 ± 7,1*
Sa-FRF 77 ± 17* 59 ± 20*
Sb-FRF 82 ± 8,2* 76 ± 9,3*
ANOVA followed by Dunnett’s test.*p < 0.05, **p < 0.01. Data are presented as
mean ± S.D (n = 5-7)
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related to decreased acid secretion, the presence of sulfhy-
dryl compounds, to nitric oxide which causes reductions
of somatostatin and gastrin, to reduced lipid peroxidation,
and to an increase in thiol groups.
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